List of Excipients in API HYDROXYZINE PAMOATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing HYDROXYZINE PAMOATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | D&C RED NO. 33 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | D&C YELLOW NO. 10 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | FD&C GREEN NO. 3 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | FD&C YELLOW NO. 6 | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | MAGNESIUM STEARATE | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | SODIUM LAURYL SULFATE | |
| Pfizer Laboratories Div Pfizer Inc | VISTARIL | hydroxyzine pamoate | 0069-5410 | SUCROSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing HYDROXYZINE PAMOATE
Detailed excipient profiles for HYDROXYZINE PAMOATE
Excipient focus: ACID YELLOW 3
HYDROXYZINE PAMOATE drug variants containing ACID YELLOW 3
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxyzine pamoate | 50090-7540 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing ACID YELLOW 3
Excipient focus: ALCOHOL
HYDROXYZINE PAMOATE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | hydroxyzine pamoate | 0904-7065 |
| State of Florida DOH Central Pharmacy | hydroxyzine pamoate | 53808-0373 |
| Cardinal Health 107 LLC | hydroxyzine pamoate | 55154-2337 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
HYDROXYZINE PAMOATE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | hydroxyzine pamoate | 52959-433 |
| Direct Rx | hydroxyzine pamoate | 61919-357 |
| TYA Pharmaceuticals | hydroxyzine pamoate | 64725-0302 |
| RedPharm Drug Inc | hydroxyzine pamoate | 67296-0152 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
HYDROXYZINE PAMOATE drug variants containing AMMONIA
HYDROXYZINE PAMOATE drug variants not containing AMMONIA
Excipient focus: ANHYDROUS LACTOSE
HYDROXYZINE PAMOATE drug variants containing ANHYDROUS LACTOSE
HYDROXYZINE PAMOATE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BLUE 1
HYDROXYZINE PAMOATE drug variants containing BLUE 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxyzine pamoate | 50090-7540 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing BLUE 1
Excipient focus: BUTYL ALCOHOL
HYDROXYZINE PAMOATE drug variants containing BUTYL ALCOHOL
HYDROXYZINE PAMOATE drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
HYDROXYZINE PAMOATE drug variants containing CELLULOSE, MICROCRYSTALLINE
HYDROXYZINE PAMOATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CI 77499
HYDROXYZINE PAMOATE drug variants containing CI 77499
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxyzine pamoate | 50090-7540 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing CI 77499
Excipient focus: CI 77891
HYDROXYZINE PAMOATE drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxyzine pamoate | 50090-7540 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing CI 77891
Excipient focus: COLLOIDAL SILICON DIOXIDE
HYDROXYZINE PAMOATE drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | hydroxyzine pamoate | 42549-528 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
HYDROXYZINE PAMOATE drug variants containing CROSCARMELLOSE SODIUM
HYDROXYZINE PAMOATE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CURRY RED
HYDROXYZINE PAMOATE drug variants containing CURRY RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxyzine pamoate | 50090-7540 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing CURRY RED
Excipient focus: D&C RED NO. 28
HYDROXYZINE PAMOATE drug variants containing D&C RED NO. 28
HYDROXYZINE PAMOATE drug variants not containing D&C RED NO. 28
Excipient focus: D&C RED NO. 33
HYDROXYZINE PAMOATE drug variants containing D&C RED NO. 33
HYDROXYZINE PAMOATE drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
HYDROXYZINE PAMOATE drug variants containing D&C YELLOW NO. 10
HYDROXYZINE PAMOATE drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxyzine pamoate | 50090-7540 |
| State of Florida DOH Central Pharmacy | hydroxyzine pamoate | 53808-0373 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
HYDROXYZINE PAMOATE drug variants containing FD&C BLUE NO. 1
HYDROXYZINE PAMOATE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
HYDROXYZINE PAMOATE drug variants containing FD&C BLUE NO. 2
HYDROXYZINE PAMOATE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C GREEN NO. 3
HYDROXYZINE PAMOATE drug variants containing FD&C GREEN NO. 3
HYDROXYZINE PAMOATE drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 40
HYDROXYZINE PAMOATE drug variants containing FD&C RED NO. 40
HYDROXYZINE PAMOATE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
HYDROXYZINE PAMOATE drug variants containing FD&C YELLOW NO. 6
HYDROXYZINE PAMOATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERROSOFERRIC OXIDE
HYDROXYZINE PAMOATE drug variants containing FERROSOFERRIC OXIDE
HYDROXYZINE PAMOATE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: FERROUS OXIDE
HYDROXYZINE PAMOATE drug variants containing FERROUS OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | hydroxyzine pamoate | 53808-0426 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing FERROUS OXIDE
Excipient focus: GELATIN
HYDROXYZINE PAMOATE drug variants containing GELATIN
HYDROXYZINE PAMOATE drug variants not containing GELATIN
Excipient focus: HYDROXYPROPYL CELLULOSE
HYDROXYZINE PAMOATE drug variants containing HYDROXYPROPYL CELLULOSE
HYDROXYZINE PAMOATE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: INDIGOTINDISULFONATE SODIUM
HYDROXYZINE PAMOATE drug variants containing INDIGOTINDISULFONATE SODIUM
HYDROXYZINE PAMOATE drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: ISOPROPYL ALCOHOL
HYDROXYZINE PAMOATE drug variants containing ISOPROPYL ALCOHOL
HYDROXYZINE PAMOATE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
HYDROXYZINE PAMOATE drug variants containing LACTOSE MONOHYDRATE
HYDROXYZINE PAMOATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
HYDROXYZINE PAMOATE drug variants containing MAGNESIUM STEARATE
HYDROXYZINE PAMOATE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
HYDROXYZINE PAMOATE drug variants containing PROPYLENE GLYCOL
HYDROXYZINE PAMOATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
HYDROXYZINE PAMOATE drug variants containing SHELLAC
HYDROXYZINE PAMOATE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
HYDROXYZINE PAMOATE drug variants containing SILICON DIOXIDE
HYDROXYZINE PAMOATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURYL SULFATE
HYDROXYZINE PAMOATE drug variants containing SODIUM LAURYL SULFATE
HYDROXYZINE PAMOATE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
HYDROXYZINE PAMOATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
HYDROXYZINE PAMOATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
HYDROXYZINE PAMOATE drug variants containing STARCH, CORN
HYDROXYZINE PAMOATE drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
HYDROXYZINE PAMOATE drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | hydroxyzine pamoate | 0069-5410 |
| Greenstone LLC | hydroxyzine pamoate | 59762-5420 |
| REMEDYREPACK INC | hydroxyzine pamoate | 70518-0500 |
| REMEDYREPACK INC | hydroxyzine pamoate | 70518-3323 |
| >Company | >Ingredient | >NDC |
HYDROXYZINE PAMOATE drug variants not containing SUCROSE
Excipient focus: TITANIUM DIOXIDE
HYDROXYZINE PAMOATE drug variants containing TITANIUM DIOXIDE
HYDROXYZINE PAMOATE drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links